Tango Therapeutics Inc (TNGX)
$6.98 $0.03 (0.42%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$800.37M -
Day's Range
$6.82 - $7.14 -
Volume
1,047,127 -
52 Week Low / High
$5.15 - $13.03 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
TNGX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 6
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $17.60
- Target Price
Company News
-
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity — May 23rd, 2024
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity On Thursday, Tango Therapeutics Inc. (NASDAQ:TNGX) announced that it will discontinue the development of its TNG348 program. “Patient safety is always our first priority and based on emerging data from the TNG34...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$